A bioinformatics pipeline describes 390 putative, novel inhibitory receptors, to facilitate targeted therapeutic strategies for diverse immune cell types in cancer therapy.
PRNewswire Singapore October 5 A new cell therapy targeting CD7 on leukaemia cells gives a potentially effective treatment ...
Discovery could lead to development of new drugs to treat inflammation, coronary artery disease, cancer, more Steven Mansoor, ...
Steven Mansoor, M.D., Ph.D., a physician–scientist at Oregon Health & Science University, and his research team made a ...
The black widow spider is one of the most feared spider species. Its venom is a cocktail of seven different toxins that ...
Purespring Therapeutics Ltd. has raised £80 million (US$104.6 million) in a series B, putting it on course to be the first to take a gene therapy for a kidney disease into the clinic. The money ...
ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA), ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") ...
AZoLifeSciences on MSN2d
New Insights into Tissue Growth and StructureRecent advances that have enabled the growth of tissue cultures into organoids and embryoids have heightened interest as to ...
The Manila Times on MSN17d
Nxera Pharma Receives Approval of QUVIVIQ (daridorexant) 25 and 50 mg in Japan for the Treatment of InsomniaThe approval of QUVIVIQ, a novel dual orexin receptor antagonist, is based on robust clinical efficacy and safety data, including from a Phase 3 trial in Japan that met all primary and secondary endpo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback